FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Avkare Famciclovir tablets Recall

Famciclovir tablets, 500 mg, packaged in 30-count unit dose cartons, Rx only, Manufactu…

AVKARE Inc. · Pulaski, TN

Risk level
Class II
Reported by FDA
Mar 29, 2017
Recall ID
D-0610-2017
Check your lot numberHow we source this data

Summary

Avkare recalled Famciclovir tablets starting Feb 15, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0610-2017 on Mar 29, 2017. Reason: Failed impurities/ degradation specifications: Product was above specification for unknown impurities. Status: Terminated.

Why it was recalled

Failed impurities/ degradation specifications: Product was above specification for unknown impurities.

Product description

Famciclovir tablets, 500 mg, packaged in 30-count unit dose cartons, Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-307-13

Lot numbers, UPCs & expiration codes

Lot #15152, Exp. 02/2018

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0610-2017
Classification
Class II
Status
Terminated
Recall initiated
Feb 15, 2017
FDA report date
Mar 29, 2017
Quantity
116 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
AVKARE Inc.

Original FDA data

Every field from FDA enforcement report D-0610-2017, exactly as published.

Show all FDA fields
City
Pulaski
State
TN
Status
Terminated
Country
United States
Event ID
76617
Address
615 N 1st St
Code information
Lot #15152, Exp. 02/2018
Postal code
38478-2403
Report date
Mar 29, 2017
Product type
Drugs
Recall number
D-0610-2017
Classification
Class II
Recalling firm
AVKARE Inc.
Product quantity
116 cartons
Termination date
Jun 1, 2022
Reason for recall
Failed impurities/ degradation specifications: Product was above specification for unknown impurities.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Famciclovir tablets, 500 mg, packaged in 30-count unit dose cartons, Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-307-13
Distribution pattern
Nationwide
Recall initiation date
Feb 15, 2017
Initial firm notification
Letter
Center classification date
Mar 22, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0610-2017, published Mar 29, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls